The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (eGFR) formula commonly used to measure kidney function, as recommended by the National Kidney Foundation and American Society of Nephrology to support health equity. The use of race in the equation for eGFR can exacerbate disparities in health outcomes. The D.C. marketplace, known as DC Health Link, covers 100,000 enrollees and 5,300 employers in all 50 states.

Related News Articles

Headline
In this conversation, Terry Scoggin, CEO of Titus Regional Medical Center, discusses how the organization designed a system of care to ensure that every…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
The AHA’s Institute for Diversity and Health Equity will host its next Health Equity Innovation Summit in Washington, D.C., on Nov. 12 from 9:30 a.m. to 3:30 p…
Headline
AHA-member and non-member CEOs are being reminded to complete the AHA’s 2024 Governance Survey by mid-November. The survey, sent via email Aug. 20, Sept. 3,…
Headline
The AHA's Institute for Diversity and Health Equity has extended until Nov. 7 the deadline to apply for the 2025 Carolyn Boone Lewis Equity of Care Awards,…
Headline
The AHA's Institute for Diversity and Health Equity has extended until Oct. 15 the deadline to apply for the 2025 Carolyn Boone Lewis Equity of Care Awards,…